Human longevity is heritable, but genome-wide association (GWA) studies have had limited
success. Here, we perform two meta-analyses of GWA studies of a rigorous longevity …

Genetic discoveries of Alzheimer’s disease are the drivers of our understanding, and together
with polygenetic risk stratification can contribute towards planning of feasible and efficient …

Amyloid-beta 42 (Aβ42) and phosphorylated tau (pTau) levels in cerebrospinal fluid (CSF)
reflect core features of the pathogenesis of Alzheimer’s disease (AD) more directly than …

The genetic variant rs72824905-G (minor allele) in the PLCG2 gene was previously
associated with a reduced Alzheimer’s disease risk (AD). The role of PLCG2 in immune system …

Alzheimer’s disease (AD) is heterogenous at the molecular level. Understanding this
heterogeneity is critical for AD drug development. Here we define AD molecular subtypes using …

Alzheimer’s disease (AD), the leading cause of dementia, has an estimated heritability of
approximately 70% 1 . The genetic component of AD has been mainly assessed using genome-…

The detection of genetic loci associated with Alzheimer’s disease (AD) requires large numbers
of cases and controls because variant effect sizes are mostly small. We hypothesized that …

Developing Alzheimer’s disease (AD) is influenced by multiple genetic variants that are
involved in five major AD-pathways. Per individual, these pathways may differentially contribute …

Importance Some individuals who reach ages beyond 100 years in good cognitive health may
be resilient against risk factors associated with cognitive decline. Exploring the processes …

Introduction Both late-onset Alzheimer’s disease (AD) and ageing have a strong genetic
component. In each case, many associated variants have been discovered, but how much …